Finally, in a study by Chaiteerakij [84], the association between SNPs of inflammation or cancer-associated genes—including the GSTO1*A140D variant—and the CCA risk and survival was investigated in a cohort of patients and healthy controls from Minnesota (USA). This evidence concerns the gene GSTO1 and cholangiocarcinoma.